Make an Appointment

Stress and Anxiety Disorders Program

Peer-Reviewed Research Publications from the University of Michigan Anxiety Disorders Program and Trauma, Stress and Anxiety Research Group

  1. Liberzon J, Abelson JL, King A, Liberzon I: Naturalistic stress and cortisol response to awakening: Adaptation to seafaring.  Psychoneuroendocrinology 2008; 33:1023-1026.
  2. Khan S, Briggs H, & Abelson JL: Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses.  Psychiatry Research, 2008; 158(2):141-6.
  3. Gloster AT, Richard DCS, Himle JA, Koch E, Anson H, Lokers L, & Thornton J: Accuracy of retrospective memory and covariation estimation in patients with obsessive-compulsive disorder.  Behaviour Research and Therapy, 2008; 46(5): 642-655.
  4. Muroff JR, Jackson JJ, Mowbray CT, & Himle JA: Gender, patient volume and time on clinical diagnostic decision-making in the psychiatric emergency setting (PES).  General Hospital Psychiatry, 2007; 29(6):481-8.
  5. Abelson JL, Khan S, Liberzon I, Young EA: HPA axis activity in patients with panic disorder:  Review and synthesis of four studies.  Depression & Anxiety, 2007; 24:66-76.
  6. Taylor SF and Liberzon I: Neural correlates of emotion regulation in psychopathology Trends in Cognitive Science,2007; 11(10):413-8.
  7. Seng JS, Schrot JA, & Liberzon I: Service use data analysis of pre-pregnancy psychiatric and somatic diagnoses in women with hyperemesis gravidarum. Journal of Psychsomatics,2007; 28(4):209-17.
  8. Britton JC, Ho SH, Taylor SF, Keith D, & Liberzon I: Neuroticism associated with neural activation patterns to positive stimuli. Psychiatric research: Neuroimaging,2007; 156(3):263-7.
  9. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Van Etten-Lee ML, Fischer DJ, Himle JA, Bivens NC, Wu X, Roe CA, Hennessey KA, Dickel DE, Leventhal BL, & Cook EH:  Evidence for a Susceptibility Locus on Chromosome 10p15 in Early-onset obsessive-compulsive disorder.  Biological Psychiatry, 2007;62(8):856-62.
  10. Abelson JL, Khan S, Lyubkin M, & Giardino N: Respiratory irregularity and stress hormones in panic disorder: Exploring potential linkages.  Depression & Anxiety, 2007; epublished 7 Jun 2007.
  11. Liberzon I, King AP, Britton JC, Phan L, Abelson JL, Taylor SF:  Paralimbic and medial prefrontal cortical involvement in neuroendocrine responses to traumatic stimuli.  Am J Psychiatry, 2007; 164:1250-1258.
  12. Liberzon I, Taylor SF, Phan KL, Britton JC, Fig LM, Bleuller JA, Koeppe RA, & Zubieta JK: Altered Central m-Opioid Receptor Binding Following Psychological Trauma. Biological Psychiatry, 2007;61(9):1030-1038.
  13. Dickel DE, Veenstra-VanderWelle J, Bivens NC, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH, & Hanna GL:  Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.  Biological Psychiatry, 2007; 61:322-329.
  14. Himle JA, Fischer DJ, Muroff JR, Van Etten ML, Lokers LM, Abelson JL, & Hanna GL:  Videoconferencing-based cognitive-behavioral treatment for obsessive-compulsive disorder.  Behavior Research and Therapy, 2006; 44:1821-1829.
  15. Liberzon I, Abelson JL, Amdur RL, King AP, Cardneau JD, Henke P, & Graham LM: Increased psychiatric morbidity after abdominal aortic surgery: Risk factors for stress-related disorders.  J Vasc Surg, 2006; 43:929-934.
  16. Taylor SF, Martis B, Fitzgerald KD, Welsh RC, Abelson JL, Liberzon I, Himle JA, & Gehring WJ:  Medical frontal cortex activity and loss-related responses to errors.  J. Neurosci, 2006; 26:4063-4070.
  17. Britton, JC, Taylor SF, Berridge KC, Mikels JA, & Liberzon I: Differential Subjective and Psychophysiological Responses to Social and Non-social Emotional Stimuli. Emotion, 2006; 6(1):150-5.
  18. Britton JC, Phan KL, Taylor SF, Welsh RC, Berridge KC, & Liberzon I:  Neural correlates of social and nonsocial emotions:  An fMRI study.  Neuroimage, 2006; 31(1):397-409.
  19. Phan KL, Britton JC, Taylor SF, Fig LM, & Liberzon I:  Cortico-Limbic Blood Flow During Non-traumatic Emotional Processing in PTSD. Archives of General Psychiatry, 2006; 63:184–192.
  20. Britton JC, Taylor SF, Keith D. Sudheimer KD, & Liberzon I:  Facial expressions and complex IAPS pictures: Common and Differential Networks. Neuroimage, 2006; 31(2):906-919.
  21. Mclean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, Park KM, Liberzon I, Seng A, Gracely RH, Baraniuk JN, & Clauw DJ:  Cerebrospinal fluid corticotrophin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.  Neuropsychopharmacology, 2006; 12:2776-82.
  22. Liberzon I and Martis B: Neuroimaging studies of emotional responses in PTSD. In Psychobiology of Posttraumatic Stress Disorder: A decade of progress. AnnalsYorkAcademy of Science, 2006; 1071:87-109.
  23. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DF, Van Etten ML, Himle JA, Leventhal BL, Cook EH, & Hanna GL: Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Archives of General Psychiatry, 2006; 63:778-785.
  24. Himle JA, Van Etten ML, Janeck AS, & Fischer DJ:  Insight as a predictor of outcome in behavioral group treatment for obsessive-compulsive disorder.  Cognitive Therapy and Research, 2006; 30:661-666.
  25. Abelson JL, Curtis GC, & Uhde TW: Twenty-four hour growth hormone secretion in patients with panic disorder.  Psychoneuroendocrinology, 2005; 30: 72-79.
  26. Fitzgerald KD, Welsh RC, Gehring WJ, Abelson JL, Himle JA, Liberzon I, & Taylor SF:  Error-related hyperactivity of the anterior cingulate cortex in obsessive compulsive disorder.  Biol Psychiatry, 2005; 57:287-294.
  27. Abelson JL, Liberzon I, Young EA, Khan S: Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Arch Gen Psychiatry, 2005; 62:668-675.
  28. Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF, Martis B, & Giordani B: Deep brain stimulation for refractory obsessive compulsive disorder.  Biol Psychiatry, 2005; 57:510-516.
  29. Young EA, Abelson JL, & Cameron OG: Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man.  Psychoneuroendocrinology, 2005, 30:807-814.
  30. McLean SA, Clauw DJ, Abelson JL, Liberzon I: The development of persistent pain and psychological morbidity after motor vehicle collision: Integrating the potential role of stress response systems into a biopsychosocial model.  Psychosom Med, 2005; 67:783-790.
  31. Britton JC, Phan KL, Taylor SF, Fig LM, Liberzon I: Cortico-limbic Blood Flow in Posttraumatic Stress Disorder during Script Driven Imagery. Biological Psychiatry, 2005;  57(8): 832-840.
  32. Hanna GL, Fischer DJ, Chadha KR, Himle JA, & Van Etten M: Familial and sporatic subtypes of early-onset Obsessive Compulsive disorder. Biological Psychiatry, 2005; 57:895-900.
  33. Hanna GL, Fingerlin TE, Himle JA, Curtis GC, & Boehnke M: A Family Study of Obsessive-Compulsive Disorder with Pediatric Probands. American Journal of Medical Genetics, 2005; 134:13-19.
  34. Hanna GL, Fingerlin T, Himle JA, & Boehnke M: Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Human Heredity, 2005; 60:1-9.
  35. Khan S, Liberzon I, & Abelson JL:  Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin. Psychiatry Research, 2004; 126:189-195.
  36. Khan S, Liberzon I, & Abelson JL: Effects of propranolol on symptom and endocrine responses to pentagastrin.  Psychoneuroendocrinology, 2004; 29:1163-1171.
  37. Young EA, Abelson JL, & Cameron OG:  Effect of comorbid anxiety disorders on HPA response to a social stressor in major depression.  Biol Psychiatry, 2004; 56:113-120.
  38. Cameron OG, Abelson JL, & Young EA: Anxious and depressive disorders and their comorbidity: Effect on central nervous system noradrenergic function.  Biol Psychiatry, 2004; 56: 875-883.
  39. Young EA, Abelson JL, & Lightman SL:  Cortisol pulsatility and its role in stress regulation and health.  Front Neuroendocrinol, 2004; 25:69-76.
  40. Khan S and Liberzon I: Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacolog, 2004; March 172(2):225-9.
  41. Phan KL, Taylor SF, Welsh RC, Ho SH, Britton JC, & Liberzon I: Neural correlates of individual ratings of emotional salience: a trial-related fMRI study. NeuroImage,2004; 21(2):768-780.
  42. Phan KL, Wager TD, Taylor SF, & Liberzon I:  Functional Neuroimaging Studies of Human Emotions. CNS Spectrums, 2004; 9(4):258-267.
  43. Koch EI, Spates R, & Himle JA: Comparison of Behavioral and Cognitive-Behavioral One-Session Exposure Treatments for Small Animal Phobias. Behaviour Research and Therapy, 2004; 42:1483-1504.
  44. Alpers GW, Abelson JL, Wilhelm FH, & Roth WT: Salivary cortisol responses to exposure treatment in driving phobics.  Psychosom Med, 2003; 65:679-687.
  45. Liberzon I, Phan KL, Khan S, & Abelson JL: Role of the GABA-A receptor in anxiety: Evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies.  Current Neuropharmacology, 2003; 1:267-283.
  46. Schmeelk-Cone KH, Zimmerman MA, & Abelson JL: The buffering effects of active coping on the relationship between SES and cortisol among African American young adults.  Behavioral Medicine, 2003; 29:85-94.
  47. Phan KL, Taylor SF, Welsh RC, Decker LR, Nichols TE, Noll DC, Britton JC, & Liberzon I: Activation of the Medial Prefrontal Cortex and Extended Amygdala by Individual Ratings of Emotional Arousal: An fMRI Study.  Biological Psychiatry, 2003; 53:211-215.
  48. Taylor SF, Phan KL, Decker LR, & Liberzon I:  Subjective rating of emotionally salient stimuli modulates limbic activity. NeuroImage,  2003; 18:650-659.
  49. Liberzon I, Phan KL, Decker LR, & Taylor SF: Extended amygdala and emotional salience: A PET investigation of positive and negative affect. Neuropsychopharmacology, 2003; 28:726-733.
  50. Wager TD, Phan KL, Liberzon I, & Taylor SF:  Valence, gender, and lateralization of functional brain anatomy in emotion: A meta-analysis of findings from neuroimaging. NeuroImage, 2003; 19(3):513-31.
  51. Liberzon I and Phan KL: Brain Imaging Studies of Posttraumatic Stress Disorder. CNS Spectrums, 2003; 8(9):641-650.
  52. Phan KL, Liberzon I, Welsh RC, Britton JC, & Taylor SF: Habituation of rostral anterior cingulate cortex to repeated emotional salient pictures.  Neuropsychopharmacology,  2003; 28 (7):1344-50.
  53. Liberzon I, Phan KL, & Britton JC: Neural Correlates of Symptom Provocation in Posttraumatic Stress Disorder. Stress, 2003;6(3):151-156.
  54. Himle JA, Fischer DJ, Van Etten ML, Janeck AS, & Hanna GL:  Group behavioral therapy for adolescents with tic-related and non-tic-related obsessive-compulsive disorder.  Depression and Anxiety, 2003; 17:73-78.
  55. Himle JA, Van Etten M, & Fischer DJ: Group cognitive-behavioral therapy for obsessive-compulsive disorder: A review. Brief Treatment and Crisis Intervention, 2003; 3:217-229.
  56. Liberzon I, Taylor SF, Fig LM, Phan KL, Koeppe RA, & Zubieta JK:  Mu-opioid Receptors and Limbic Responses to Aversive Emotional Stimuli. Proceedings of the NationalAcademy of Sciences of the Unites States of America (PNAS),  2002;99(10):7084-7089.
  57. Phan KL, Wager T, Taylor SF, & Liberzon I:  Functional Neuroanatomy of Emotion:  A Meta-analysis of Emotion Activation Studies in PET and fMRI.  NeuroImage, 2002;  16:331-348.
  58. Albucher RC and Liberzon I: Psychopharmacological Treatment in PTSD: a Critical Review. Journal of Psychiatric Research, 2002; 36:355-367.
  59. Hanna GL, Veenstra-Vander Weele, Cox JN, Boehnke M, Himle J, Curtis GC, Leventhal BL, & Cook EH:  Genome-Wide Linkage Analysis of Families with Obsessive-Compulsive Disorder Ascertained through Pediatric Probands. Neuropsychiatric Genetics, 2002; 114:541-552.
  60. Hanna GL, Piacentini J, Cantwell D, Fischer DJ, Himle JA, & Van Etten ML: Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents. Depression and Anxiety, 2002; 16:59-63.
  61. Abelson JL and Young EA: Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition.  Psychoneuroendocrinology, 2001; 28:169-180.
  62. Abelson JL, Weg JG, Nesse RM, & Curtis GC: Persistent respiratory irregularity in patients with panic disorder.  Biol Psychiatry, 2001; 49:588-595.
  63. Abelson JL, Le Melledo JM, & Bichet DG: Dose response of arginine vasopressin to the CCK-B agonist pentagastrin. Neuropsychopharmacology, 2001; 24:161-169.
  64. Himle JA, Rassi S, Haghighatgou H, Krone KP, Nesse RM, & Abelson J: Group behavioral therapy of obsessive-compulsive disorder: Seven versus twelve week outcomes.  Anxiety and Depression, 2001; 13:161-165.
  65. Amdur RL and Liberzon I: The structure of Posttraumatic stress disorder symptoms in combat veterans: a confirmatory factor analysis of the impact of event scale. Journal of Anxiety Disorders, 2001; 15:345-357.
  66. Himle JA:  Medication consultation: The non-physician perspective.  Psychiatric Annals, 2001; 31:623-628.
  67. Gerhing WJ, Himle JA, & Neisenson LG: Action monitoring dysfunction in obsessive-compulsive disorder.  Psychological Science, 2000; 11:1-6.
  68. Huang MP, Himle J, Beier K, Alessi NE: Vivid visualization in the experience of phobia in virtual environments: Preliminary results. Cyberpsychology and Behavior, 2000; 3:315-320.
  69. Rajarethinam RP, Abelson JL, & Himle J: Acute onset and remission of obsessions and compulsions following medical illness and stress.  Anxiety and Depression, 2000; 12:238-240.
  70. Amdur RL and Liberzon I: Emotional processing in combat-related PTSD: a comparison with traumatized and normal controls. Journal of Anxiety Disorders, 2000; 14(3):219-38.
  71. Taylor SF, Liberzon I, & Koeppe RA: The effect of grade aversive stimuli on limbic and visual activation. Neuropsychologia, 2000; 38(10):1415-1425.
  72. Liberzon I, Taylor SF, Fig LM, Decker LR, Koeppe RA, & Minoshima S: Limbic activation and psychophysiological response to aversive visual stimuli: interaction with cognitive task. Neuropsychopharmacology, 2000; 23:508-16.
  73. Abelson JL and Liberzon I: Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. Neuropsychopharmacology, 1999; 21:485-494.
  74. Himle JA, Abelson JL, Haghightgou H, Hill EM, Nesse RM, & Curtis GC: Effect of Alcohol on Social Phobic Anxiety. Am J Psychiatry, 1999; 156:1237-1243.
  75. Liberzon I, Abelson JL, Flagel SB, Raz J, & Young EA: Neuroendocrine and psychophysiologic responses in PTSD: A symptom provocation study. Neuropsychopharmacology, 1999; 21:40-50.
  76. Liberzon I, Lopez J, Vazquez D, Flagel SB, & Young EA: Differential regulation of hippocampal glucocorticoid receptors and negative feedback: relevance to PTSD. Journal of Neuroendocrinology, 1999; 11: 11-17.
  77. Liberzon I, Taylor SF, Amdur R, Jung TD, Chamberlain KR, Minoshima S, Koeppe RA, & Fig LM: Brian activation in PTSD in response to trauma-related stimuli. Biological Psychiatry, 1999; 45:817-826.
  78. Abelson JL: Hypothalamic-pituitary-adrenal axis activity in psychiatric disorders: Focus on panic disorder. Essential Psychopharmacology, 1998; 2:331-350.
  79. Albucher RC, Abelson JL, & RM Nesse. Defense mechanism changes in successfully treated patients with obsessive-compulsive disorder. American Journal of Psychiatry, 1998. 155(4):558-9.
  80. Huang MP, Rajarethinam RP, Abelson JL, & Alessi NE: Case studies of the Internet: Experiences at an Anxiety Disorders Program. MD Computing, 1998; 15:238-241.
  81. Young EA, Nesse RM, Weder A, & Julius S: Anxiety and cardiovascular reactivity in the Tecumseh population. Journal of Hypertension, 1998; 16:1727-1733.
  82. Kales HC, Abelson JL, & Riba MB:  The relevance of transference during medication management: A case of erotized transference.  Jefferson Journal of Psychiatry, 1998; 14:30-40.
  83. Goldfinger D, Amdur R, & Liberzon I: Psychophysiologic responses to the Rorschach in PTSD patients, non-combat and combat controls. Depression and Anxiety, 1998; 8:104-111.
  84. Goldfinger D, Amdur R, & Liberzon I:  Rorschach in Vietnam Veterans with PTSD, normal and combat controls. Depression and Anxiety, 1998; 8:112-120.
  85. Casada J, Amdur RL, & Liberzon I: Psychophysiologic assessment of PTSD: general hyperresponsivness vs. trauma specificity. Biological Psychiatry, 1998; 44(10):1037-1045.
  86. Taylor SF, Liberzon I,  Fig LM, & Koeppe RA:  The effect ofemotional content on visual recognition memory: A PET activation study. Neuroimage, 1998; 8:188-197.
  87. Hanna GL, Himle JA, Koram DQ, Veenstra-Vander Weele J, Leventhal BL, & Cook EH: Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology, 1998; 18:102-111.
  88. Fischer DJ, Himle JA, & Hanna GL:  Group behavioral therapy for adolescents with obsessive-compulsive disorder: Preliminary outcomes.  Research on Social Work Practice, 1998; 8:629-636.
  89. Fischer DJ, Himle JA, & Hanna GL: Symptom profiles of adult versus childhood OCD. Depression and Anxiety, 1997; 4:237-239.
  90. Young EA, Abelson JL, Curtis GC, & Nesse RM: Childhood adversity and vulnerability to mood and anxiety disorders. Depression, 1997; 5:66-72.
  91. Curtis GC, Abelson JL, & Gold PW: ACTH and cortisol responses to CRH: Changes in panic disorder and effects of alprazolam treatment.  Biol Psychiatry, 1997; 41:76-85.
  92. Liberzon I, Taylor SF, Fig LM, & Koeppe RA: Alteration of thalamo cortical perfusion ratio during PTSD flashback. Depression and Anxiety, 1997; 4:146-150.
  93. Liberzon I, Krstov M, & Young EA: Stress-Restress: Effects on ACTH and fast feedback.  Psychoneuroendocrinology. 1997; 22(6):443-453.
  94. Liberzon I and Young EA: Effects of stress and glucocorticoids on CNS oxytocin receptors binding.  Psychoneuroendocrinology, 1997; 22:411-422.
  95. Liberzon I,  Trujillo KA, Akil H, & Young EA:  Motivational properties of oxytocin  in conditioned place preference paradigm.  Neuropsychopharmacology, 1997; 17:353-359.
  96. Abelson JL and Curtis GC: Hypothalamic-Pituitary-Adrenal Axis Activity in Panic Disorder: 24-Hour Secretion of Adrenocorticotropin and Cortisol. Archives of General Psychiatry, 1996; 53:323-331.
  97. Abelson JL and Curtis GC: Hypothalamic-Pituitary-Adrenal Axis Activity in Panic Disorder: Pre-Treatment Cortisol Predicts Long-Term Outcome. American Journal of Psychiatry, 1996; 153:1:69-73.
  98. Amdur R and Liberzon I: Dimensionality of Dissociation in Subjects with PTSD. Dissociation, 1996; 9: 118-124.
  99. Wittchen H-U, Zhao S, Abelson JM, Abelson JL, & Kessler RC: Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol Med, 1996; 26:1169-1177.
  100. Abelson JL, Weg JG, Nesse RN, & Curtis, GC: Neuroendocrine responses to laboratory panic: Cognitive intervention in the doxapram model. Psychoneuroendocrinology, 1996; 21(4):375-90.
  101. Abelson JL, Nesse RM, Weg, JG, & Curtis GC: Respiratory Psychophysiology and Anxiety: Cognitive Intervention in the Doxapram Model of Panic. Psychosomatic Medicine, 1996; 58:302-313.
  102. Cameron OG, Smith CB, Nesse RM, Hill EM, Hollingsworth PJ, Abelson JL, Hariharan M, & Curtis GC: Platelet Alpha2-Adrenoreceptors, Catecholamines, Hemodynamic Variables, and Anxiety in Panic Patients and Their Asymptomatic Relatives. Psychosomatic Medicine, 1996; 58:289-301.
  103. Abelson JL, Curtis GC, Cameron OG: Hypothalamic-pituitary-adrenal axis activity in panic disorder: Effects of alprazolam on 24-hour secretion of adrenocorticotropin and cortisol.  J Psychiat Res, 1996; 30:79-93.
  104. Abelson JL and Curtis GC:  Hypothalamic-pituitary-adrenal axis activity in panic disorder: Prediction of long-term outcome by pre-treatment cortisol levels.  Am J Psychiatry, 1996; 153:69-73.
  105. Ronis D, Bates EW, Garfein AJ, Buit BK, Falcon SP, and Liberzon I:  Longitudinal patterns of care for patients with Posttraumatic Stress Disorder. Journal of Traumatic Stress, 1996; 9: 763 – 781.
  106. Thyer B A, Himle J. & Santa C: Applied behavior analysis in social and community action. Behaviorists for Social Action Journal, 1996; 5:14-16.
  107. Nesse RM and Abelson JL: Natural selection and fear regulation mechanisms. Behavioral and Brain Sciences, 1995; 18(2):309-310.
  108. Schweitzer PB, Nesse RM, Fantone RF, & Curtis GC: Outcomes of Group Cognitive and Behavioral Training in the Treatment of Panic Disorder and Agoraphobia. Journal of the American Psychiatric Nurses Association, 1995; 1:3:83-90.
  109. Abelson JL: Cholecystokinin in psychiatric research: A time for cautious excitement (review/editorial). J Psychiat Res, 1995; 29:389-396.
  110. Abelson JL, Curtis GC, Nesse R.M., Fantone R, Pyke RE, & Bammert-Adams J.: The Effects of Central Cholecystokinin Receptor Blockade on Hypothalamic-Pituitary-Adrenal and Symptomatic Responses to Overnight Withdrawal from Alprazolam. Biological Psychiatry, 1995; 37:56-59.
  111. Thyer BA, Himle J, Curtis GC, Cameron OG & Nesse RM: A comparison of panic disorder and agoraphobia with panic attacks. Comprehensive Psychiatry, 1995; 26:208-214.
  112. Himle JA, Bordnick PS, & Thyer BA: A comparison of trichotillomania and obsessive-compulsive disorder. Journal of Psychopathology and Behavioral Assessment, 1995; 17:51-260.
  113. Abelson JL, Nesse RM, Vinik I, & Aaron I: Pentagastrin infusions in patients with panic disorder II Neuroendocrinology. Biological Psychiatry, 1994; 36:84-96.
  114. Abelson JL and Nesse RM: Pentagastrin infusions in patients with panic disorder I. Symptoms and cardiovascular responses. Biological Psychiatry, 1994; 36:73-83.
  115. Nesse RM: Computer emotions and mental software. Social Neuroscience Bulletin, 1994; 7(2): 36-37.
  116. Marks IM and Nesse RM: Fear and fitness: An evolutionary analysis of anxiety disorders. Ethology and Sociobiology, 1994; 15:247-261.
  117. Nesse RM: An evolutionary perspective on substance abuse. Ethology and Sociobiology, 1994; 15:339-348.
  118. Nesse RM and Klaas R: Risk perception by patients with anxiety disorder. Journal of Nervous and Mental Disease, 1994; 182:465-470.
  119. Taren JA, Curtis GC, & Gebarski SS: Late local and remote structural changes after capsulotomy for obsessive compulsive disorder. Stereotactic Functional Neurosurgery, 1994; 63:1-6.
  120. Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis GC, Hippius H, Maier W, Shera D, & Klerman G: Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo. European Neuropsychopharmacology, 1994; 4:1:47-53.
  121. Himle JA: What is bashful bladder syndrome? Hospital Medicine, 1994; 30:55.
  122. Curtis GC, Massana J, Udina C, Ayuso JL, Cassano GB, & Perugi G: Maintenance Drug Therapy of Panic Disorder. Journal of Psychiatric Research, 1993; 27:suppl. 1:127-142.
  123. Curtis GC: Terapia De Mantenimiento Del Trastorno De Panico. Psiquiatria, 1993; 1:54-58.
  124. Abelson JL and Curtis GC: Discontinuation of Alprazolam After Successful Treatment of Panic Disorder: A Naturalistic Follow-up Study. J. Anxiety Disorders, 1993; 7:107-117.
  125. Lee YJ, Curtis GC, Weg JG, Abelson JL, Modell JG, & Campbell KM: Panic Attacks Induced by Doxapram. Biology Psychiatry, 1993; 33:295-297.
  126. Abelson JL and Alessi NE: Discussion of "Child Panic Revisited". J Am Acad Child Adol Psychiatry, 1992; 31:114-116.
  127. Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, & Curtis GC: Endocrine, Cardiovascular, and Behavioral Responses to Clonidine in Patients with Panic Disorder. Biological Psychiatry, 1992; 32:18-25.
  128. Cross-National Collaborative Panic Study, Second Phase Investigators: Drug Treatment of Panic Disorder. Comparative Efficacy of Alprazolam, Imipramine, and Placebo. British Journal of Psychiatry, 1992; 160:191-202.
  129. Thyer BA, Himle JA, & Schweitzer PB: Birth order and obsessive-compulsive disorder. Anxiety Practice Journal, 1992; 1:9-34.
  130. Curtis GC: PET Findings in Panic, Anxiety, and Phobic Disorders. Annals of Clinical Psychiatry, 1991; 3:2:111-14.
  131. Abelson JA, Nesse RM, & Vinik A: Stimulation of corticotrophin release by pentagastrin in normal subjects and patients with panic disorder. Biological Psychiatry, 1991; 29:1220-1223.
  132. Krone KP, Himle JA, & Nesse RM: A standardized behavioral group treatment program for obsessive-compulsive disorder: preliminary outcomes. Behavior Research and Therapy, 1991; 29:627-631.
  133. Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, & Curtis GC: Blunted Growth Hormone Response to Clonidine in Patients with Generalized Anxiety Disorder. Archives of General Psychiatry, 1991; 48:157-162.
  134. Himle J, Crystal D, Curtis GC, & Fluent TE: Mode of onset of simple phobias: further evidence of heterogeneity. Psychiatry Research, 1991; 36:37-431.
  135. Himle J & Hill E.: Alcohol abuse and the anxiety disorders. Journal of Anxiety Disorders, 1991; 5:237-245.
  136. Panzer MJ, DeQuardo JR, & Abelson JL:  Delayed diagnosis of a frontal meningioma.  Annals of Clinical Psychiatry, 1991; 3:259-262.
  137. Abelson JA, Nesse RM, & Vinik A: Treatment of panic-like attacks with a long-acting analogue of somatostatin. Journal of Clinical Psychopharmacology, 1990; 10: 128-132.
  138. Nesse RM: Evolutionary explanations of emotions. Human Nature, 1990; 261-289.
  139. Starkman MN, Cameron OG, Nesse RM, & Zelnik T: Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosomatic Medicine, 1990; 52:129-142.
  140. Cameron OG, Smith CB, Lee MA, Hollingsworth PJ, Hill EM, & Curtis GC: Adrenergic Status in Anxiety Disorders: Platelet Alpha2-Adrenergic Receptor Binding, Blood Pressure, Pulse and Plasma Catecholamines in Panic and Generalized Anxiety Disorder Patients and in Normal Subjects, Biological Psychiatry, 1990; 28:3-20.
  141. Lee MA, Cameron OG, Gurguis GNM, Glitz DA, Smith CB, Hariharan M, Abelson JL, & Curtis GC: Alpha2-Adrenoreceptor Status in Obsessive-Compulsive Disorder. Biological Psychiatry, 1990; 27:1083-1093.
  142. Mountz JM, Modell JG, Wilson M, Curtis GC, Lee MA, Schmaltz S, & Kuhl DE: Positron Emission Tomographic Evaluation of Cerebral Blood Flow During State-Anxiety in Simple Phobia. Archives of General Psychiatry, 1989; 46:501-504.
  143. Himle JA, McPhee KM, Cameron OG, & Curtis GC: Simple Phobia: Evidence for Heterogeneity. Psychiatry Research, 1989; 28:25-30.
  144. Modell JG, Himle J, Nesse RM, Mountz JM, & Schmaltz S: Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder. Journal of Anxiety Disorders, 1989; 3:287-293.
  145. Modell JG, Mountz JM, Curtis GC, & Greden JF: Neurophysiologic Dysfunction in Basal Ganglia/Limbic Striatal and Thalamocortical Circuits as a Pathogenetic Mechanism of Obsessive-Compulsive Disorder. Journal of Neuropsychiatry, 1989; 1:1:27-36.
  146. Hariharan M, VanNoord T, Cameron OG, Curtis GC, Ostrow DG, & Greden JF: Free 3-Methoxy-4-hydroxphenylglycol Determined in Plasma by Liquid Chromatography with Coulometric Detection. Clin. Chem., 1989; 35:2:202-205.
  147. Himle J & Thyer BA: Clinical social work and obsessive-compulsive disorder. Behavior Modification, 1989; 13:459-470.
  148. Modell J G, Himle J, & Schmaltz S.: Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder. Journal of Anxiety Disorders, 1989; 3:287-293.
  149. Thyer BA, Himle J, & Miller-Gogoleski MA: Parental death is not a precursor to panic disorder: Acommunity based replication. Phobia Practice and Research Journal, 1989; 2:29-36.`
  150. Himle J, Himle DP & Thyer BA: Irrationality and the anxiety disorders. Journal of Rational Emotive and Cognitive Behavior Therapy, 1989; 7:155-165.
  151. Hanna GL, Himle JA, Koram DQ, Veenstra-Vander Weele J, Leventhal BL, & Cook EH: Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology, 1989; 18:102-111.
  152. Abelson JL and Curtis GC:  Cardiac and neuroendocrine responses to exposure therapy in height phobics: Desynchrony within the "physiological response system".  Behav Res Ther, 1989; 27:561-567.
  153. Green MA and Curtis GC, Personality Disorders in Panic Patients: Response to Termination of Anti-panic Medication. Journal of Personality Disorders, 1988; 2:(4): 303-314.
  154. Cameron OG, Kuttesch D, McPhee K, & Curtis GC: Menstrual Fluctuation in the Symptoms of Panic Anxiety. Journal of Affective Disorders, 1988; 15:169-174.
  155. Gurgis NM, Cameron OG, Ericson WA, &Curtis GC: The Daily Distribution of Panic Attacks. Compr. Psychiatry, 1988; 29:1-3.
  156. Nesse RM: Panic disorder: An evolutionary view. Psychiatric Annals, 1988; 18:8:478-483.
  157. Cameron OG, Nesse RM: Systemic hormonal and physiological abnormalities in anxiety disorders: A review. Psychoneuroendocrinology, 13:287-307, 1988.
  158. Thyer BA, Himle J & Fischer D: Is parental death a selective precursor to either panic disorder or agoraphobia? A test of the separation anxiety hypothesis. Journal of Anxiety Disorders, 1988; 2:333-338.
  159. Himle J, Thyer BA & Fischer DJ: Prevalence of smoking among anxious outpatients. Phobia Practice and Research Journal, 1988; 1:25-31.
  160. Nesse RM: An evolutionary perspective on panic disorder and agoraphobia. Ethology and Sociobiology, 1987; 8:73S-83S.
  161. Cameron OG, Lee MA, Curtis GC, & McCann D: Endocrine and Physiological Changes during "Spontaneous" Panic Attacks. Psychoneuroendocrinology, 1987; 12:5:321-331.
  162. Cameron OG, Liepman MR, Curtis GC, & Thyer BA: Ethanol Retards Desensitization of Phobias in Non-Alcoholics. Br. J. Psychiatry, 1987; 150:845-849.
  163. Cameron OG, Curtis GC, Zelnik T, McCann D, Roth T, Guire K, & Huber-Smith M: Circadian Fluctuation of Plasma Epinephrine in Supine Humans. Psychoneuroendocrinology, 1987; 12:41-51.
  164. Thyer BA & Himle J: Phobic and Panic anxiety: how do they differ? Journal of Anxiety Disorders, 1987; 1:59-67.
  165. Cameron OG, Kerber K, & Curtis GC: Obsessive-Compulsive Disorder and the DST. (Letter) Psychiatry Research, 1986; 19: 329-330.
  166. Cameron OG, Thyer BA, Fechner S, Nesse RM, & Curtis GC: Behavior Therapy of Phobias: Predictors of Outcome. (Letter) Psychiatry Research, 1986; 19:245-246.
  167. Nesse R M, Curtis GC, Cameron OG, & Lee MA: Normal Intense Fear in Panic Disorder or Agoraphobic patients on Antipanic Medication. (Letter) Am. J. Psychiatry, 1986; 143:7.
  168. Huber-Smith MJ, Nesse RM, Maxhan M, & McCann D: Evaluation of plasma 3-methoxy-4-hydroxyphenylglycol (MHPG). Journal of Chromatography, 1986; 377:91-99.
  169. Thyer BA, Nesse RM, Curtis GC, & Cameron OG: Panic Disorder: A Test of the Separation Anxiety Hypothesis. Behav. Res. Ther., 1986; 24:209-211.
  170. Pegeron JP, Curtis GC, & Thyer BA: Simple Phobia Leading to Suicide: A Case Report. The Behavior Therapist, 1986; 9:134-135.
  171. Cameron OG, Thyer BA, Nesse RM, & Curtis GC: Symptom Profiles of Patients with DSM-III Anxiety Disorders. Am. J. Psychiatry, 1986; 143:1132-1137.
  172. Thyer B T, Parrish R T, Himle J, Cameron OG, Curtis GC, & Nesse RM: Alcohol Abuse among Clinically Anxious Patients. Behav. Res Ther., 1986; 24:357-359.
  173. Thyer B A, Himle J & Santa C: Applied behavior analysis in social and community action. Behaviorists for Social Action Journal, 1986; 5:14-16.
  174. Thyer BA & Himle J:. Temporal relationship between panic attack onset and phobic avoidance in agoraphobia. Behaviour Research and Therapy, 1985; 23:607-608.
  175. Thyer BA and Curtis GC: On the Diphasic Nature of Vasovagal Fainting Associated with Blood-Injury-Illness Phobia. Pav. J. Biol. Sci., 1985; 20:84-87.
  176. Thyer B, Tomlin P, Curtis G, Cameron O, & Nesse R: Diagnostic and Gender Differences in the Expressed Fears of Anxious Patients. J. Behav. Ther. Exp. Psychiatry, 1985; 16:111-115.
  177. Thyer BA, Himle J, Curtis GC: Blood Injury-Illness Phobia: A Review: J. Clin. Psychol., 1985; 41:451-459.
  178. Falcon S, Ryan C, Chamberlain K, & Curtis G: Tricyclics: Possible Treatment for Post Traumatic Stress Disorder. J. Clin. Psychiatry, 1985; 46:385-388.
  179. Nesse RM, Curtis GC, Thyer BA, McCann DS, Huber-Smith MJ, & Knopf RF: Endocrine and Cardiovascular Responses During Phobic Anxiety. Psychosom. Med., 1985; 47:320-332.
  180. Thyer B, Nesse R, Cameron O, & Curtis GC: Agoraphobia: A Test of the Separation Anxiety Hypothesis. Behav. Res. Ther., 1985; 23:75-78.
  181. Nesse RM, Cameron OG, Buda AJ, McCann DS, Curtis GC, & Huber-Smith MJ: Urinary Catecholamines and Mitral Valve Prolapse in Panic-Anxiety Patients. Psychiatry Research, 1985; 14:57-74.
  182. Rainey JR and Nesse RM: Psychobiology of anxiety and anxiety disorders. In Psychiatric Clinics of North America, Vol 8, pp. 133-144, 1985. Curtis GC, Thyer BA, Rainey J (eds); Saunders, Philadelphia.
  183. Starkman MN, Zelnik T, Nesse RM, & Cameron OC: Anxiety in patients with pheochromocytoma. Archives of Internal Medicine, 1985; 145:248-252.
  184. Thyer BA, Himle J, Curtis GC, Nesse RM, & Cameron OG: Ages of Onset of DSM-III Anxiety Disorders. Compr. Psychiatry, 1985; 26:113-122.
  185. Thyer BA, Himle J, Curtis GC, Cameron OG, & Nesse RM: A Comparison of Panic Disorder and Agoraphobia with Panic Attacks. Compr. Psychiatry, 1985; 26:208-214.
  186. Thyer BA, Himle J & Curtis GC: Blood-injury-illness phobia: a review. Journal of Clinical Psychology, 1985; 41:451-459.
  187. Cameron OG, Smith CB, Hollingsworth PJ, Nesse RM, & Curtis GC: Platelet Alpha-2-Adrenoreceptor Binding and Plasma Catecholamines Before and During Imipramine Treatment In Patients With Panic Anxiety. Arch. Gen. Psychiatry, 1984; 41:1144-1148.
  188. Thyer B and Curtis GC: The Effects of Ethanol Intoxication on Phobic Anxiety. Behav. Res. and Ther., 1984; 22:556-610.
  189. Thyer BA and Curtis GC: Furosemide as an Adjuct to Exposure Therapy of Psychogenic Urinary Retention. Perceptual and Motor Skills, 1984; 59:114.
  190. Tomlin P, Thyer BA, Curtis GC, Nesse RM, Cameron OG, & Wright P: Standardization of the Fear Survey Schedule Based Upon Patients with DSM-III Anxiety Disorders. J. Behav. Ther. Exper. Psychiat., 1984; 15:123-126.
  191. Nesse RM, Cameron OG, Curtis GC, McCann DS, & Huber-Smith MJ: Adrenergic Function in Panic Anxiety Patients. Arch. Gen. Psychiatry, 1984; 41:771-776.
  192. Thyer B, Curtis GC. & Fechner S: Fear of Criticism Is Not Specific to Obsessive-Compulsive Disorder. Behav. Res. Ther., 1984; 22:77-80.
  193. Thyer BA and Curtis GC: The Repeated Pretest-Posttest Single-Subject Experiment: A New Design for Empirical Clinical Practice. J. Behav. Ther.Exp. Psychiat., 1983; 14:311-315.
  194. Curtis GC and Thyer B.: Fainting on Exposure to Phobic Stimuli. Am. J. Psychiatry, 1983; 140:771-774.
  195. Nesse R.M, Carli T, Curtis GC & Kleinman PD: Pseudohallucinations in Cancer Chemotherapy Patients. Am. J. Psychiatry, 1983; 140:483-485.
  196. Van Egeren LF, Abelson JL, & Sniderman LD: Interpersonal and electrocardiographic responses of Type A's and Type B's in competitive socioeconomic games.  J Psychosom Res, 1983; 27:53-59.
  197. Nesse RM, Curtis GC, & Brown GM: Phobic Anxiety Does Not Affect Plasma Levels of Thyroid Stimulating Hormone in Man. Psychoneuroendocrinology, 1982; 7:69-74.
  198. Curtis GC, Cameron OG, & Nesse RM: Dexamethasone Suppression Test in Panic Disorder and Agoraphobia. Am. J. Psychiatry, 1982; 39:1043-1046.
  199. Curtis GC: Sensory Experiences During Treatment of Phobias by in Vivo Exposure. Am. J. Psychiatry, 1981; 138:1094-1097.
  200. Nesse R, Carli T, Curtis GC, & Kleinman PD: Pretreatment Nausea in Cancer Chemotherapy: A Conditioned Response? Psychosom. Med., 1980; 42:33-36.
  201. Nesse R, Curtis GC, Brown GM, & Rubin RT: Anxiety Induced by Flooding Therapy for Phobias Does Not Elicit Prolactin Secretory Response. Psychosom. Med., 1980; 42:25-31.
  202. Curtis GC, Nesse R, Buxton M, & Lippman D: Plasma Growth Hormone: Effect of Anxiety During Flooding in Vivo. Am.J. Psychiatry, 1979; 136:410-414.
  203. Curtis GC, Nesse R, Buxton M, & Lippman D.: Anxiety and Plasma Cortisol at the Crest of the Circadian Cycle: Reappraisal of a Classical Hypothesis. Psychosom. Med., 1978; 40:368-378.
  204. Van Egeren LF, Abelson JL, & Thornton DW:  Cardiovascular consequences of expressing anger in a mutually dependent relationship.  J Psychosom Res, 1978; 22:537-548.
  205. Carroll B, Curtis GC, & Mendels J: Cerebrospinal Fluid and Plasma Free Cortisol Concentrations in Depression. Psychiatry Med, 1976; 6:235-244.
  206. Carroll B, Curtis GC, & Mendels J: Neuroendocrine Regulation in Depression (II): Discrimination of Depressed from Non-Depressed Patients. Arch. Gen. Psychiatry, 1976; 33:1051-1058.
  207. Carroll B, Curtis GC, & Mendels J: Neuroendocrine Regulation in Depression (I): Limbic System - Adrenal Cortical Dysfunction. Arch. Gen. Psychiatry, 1976; 33:1039-1044.
  208. Carroll BJ & Curtis GC: Neuroendocrine Identification of Depressed Patients. Aust. NZ. J. Psychiat., 1976; 10:13-20.
  209. Carroll B, Curtis GC, Davies B, Mendels J, & Sugarman A: Urinary Free Cortisol Excretion in Depression. Psychol. Med., 1976; 6:43-50.
  210. Curtis GC, Buxton M, Lippman D, Nesse R, &  Wright J: "Flooding in Vivo" During the Circadian Phase of Minimal Cortisol Secretion: Anxiety and Therapeutic Success Without Adrenal Cortical Activation. Biol. Psychiatry, 1976; ll:101-107.
  211. Curtis GC; Nesse R; Buxton M, Wright J; & Lippman D: Flooding, InVivo, as Research Tool and Treatment Method for Phobias. A Preliminary Report. Compr. Psychiatry, 1976; 17:153-160.

© 2003-2013 Regents of the University of Michigan
The University of Michigan Department of Psychiatry web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site. Complete disclaimer and Privacy Statement.

Contact Web Developer